AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 161 min read$BRO

Here’s Why This Fund Sold Brown & Brown (BRO)

Parnassus Investments sold its stake in Brown & Brown (BRO) due to near-term risks, including industry downturns and integration challenges. BRO's stock fell 6.29% in one month and 27.35% over 52 weeks, closing at $67.23. The fund's Q2 2026 performance was 17.49%, outperforming the Russell 1000 Growth Index.

Original reporting
yahoo.com
Published Sep 16, 2026, 3:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 4:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Here’s Why This Fund Sold Brown & Brown (BRO) — source image
Source · yahoo.com
Decision brief

The 30-second read

$BROBearishLow
01

Why it matters

The fund's sale of BRO signals a shift in its sector weighting and may influence other institutional investors.

02

Market read

Fund disposition adds a modest bearish signal for BRO and reflects sector risk concerns.

03

What to watch

Potential upside from AI adoption in brokerage operations not fully priced in.

Relevance 4/10Novelty 5/10Timing: Q2 2026 fund letter release

Background

Parnassus Growth Equity Fund reported a 17.49% net return for Q2 2026, outperforming the Russell 1000 Growth Index.

Company-level read

Ticker impact

$BROBearishMedium confidence
Context

Parnassus Growth Equity Fund disclosed it sold its position in Brown & Brown during Q2 2026, citing near‑term industry risks.

Expected impact

Potential short‑term downside pressure

Evidence & confidence

A reputable fund exiting suggests concerns; however, no immediate large volume disclosed.

Market effects

Sector

Highlights risk in insurance brokerage sector amid industry downturn and AI integration challenges.

Regional

U.S. insurance brokerage stocks may see heightened scrutiny.

Global

Limited to U.S. equity investors.

Counterpoint

What could challenge this read

Fund exit could be a buying opportunity if broader market overreacts to sector concerns.

Key entities

  • Asset Manager
    Parnassus Investments

    Manager of the Growth Equity Fund that sold BRO shares.

  • Company
    Brown & Brown, Inc.

    Insurance brokerage firm whose shares were sold by the fund.

Read at source← All news

Related articles

SEP 16
$BROMedAI 8/10

Winners And Losers Of Q2: Baldwin Insurance Group (NASDAQ:BWIN) Vs The Rest Of The Insurance Brokers Stocks

Ryan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.

finance.yahoo.com2 min
JUL 28
$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

financialcontent.com4 min
JUL 28
$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

yahoo.com7 min
JUL 27
$BROMedAI 8/10

Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents

Brown & Brown, Inc. (NYSE:BRO) reported unaudited Q2 2026 results. Total revenues rose to $1.7 billion, up 30.4% year over year, while organic revenue fell 0.7%. Net income attributable to the company increased to $288 million, and diluted EPS was $0.84. For six months, revenues were $3.6 billion, up 33.0%.

thestarphoenix.com6 min
JUL 27
$BROMedAI 8/10

BROWN & BROWN, INC. (BRO): Results of Operations and Financial Condition

BROWN & BROWN, INC. (BRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents of 0.7%; diluted net incom

SEC EDGAR 8-K6 min